U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. Scientific Meetings, Conferences, and Workshops
  4. FDA Omics Days 2024 - Precision in Practice: Regulatory Science, Best Practices, and Future Directions in Omics - 09/12/2024
  1. Scientific Meetings, Conferences, and Workshops

Symposium | Mixed

Event Title
FDA Omics Days 2024 - Precision in Practice: Regulatory Science, Best Practices, and Future Directions in Omics
September 12, 2024

Date:
September 12, 2024
Time:
9:00 AM - 4:30 PM ET
Image
FDA Omics Days 2024 - Precision in Practice: Regulatory Science, Best Practices, & Future Directions in Omics

September 12, 2024

Where: FDA White Oak Campus Great Room and virtually via Zoom Webinar 

On This Page: FDA Omics Days 2024

View Recording - September 12 AM

View Recording - September 12 PM

View Posters

Background:

At the FDA Omics Days 2024, the FDA Omics Working Group will be hosting speakers from industry, academia, and government to discuss topics important to the FDA. This event will include sessions on contemporary topics in the fields of precision medicine, multi-omics, and One Health.

Upon registration, further information will be sent to you that includes the link for the event. The meeting will be recorded and available after the event concludes.

Poster Abstract Booklet

Agenda

Thursday, September 12, 2024

Time ET Topics
9:00 am - 9:05 am Welcome
Lerna Uzasci, Ph.D., FDA/CDRH (event co-chair)
9:05 am - 9:15 am Opening Remarks
FDA Commissioner Robert M. Califf, M.D.
9:15 am - 10:00 am Keynote: Precision medicine
Archana Chatterjee, M.D., Ph.D., Chicago Medical School, Rosalind Franklin University of Medicine and Science

10:00 am - 10:15 am

 Break
10:15 am - 11:45 am Session 1: Changing landscape of precision medicine and pharmacogenomics
Moderator: Omics Days Co-Chair Paula Hyland, D.Phil, M.P.H., FDA/CDER (event co-chair)
Stephan Kemp, Ph.D., Amsterdam UMC
Dan Theodorescu, M.D., Ph.D., Cedars-Sinai Medical Center
Douglas M. Fowler, Ph.D., University of Washington

11:45 am - 1:15 pm

 Lunch break* with poster session**

1:15 pm - 2:45 pm

 Session 2: Omics applications on safety and efficacy for product development
Moderator: Jessica Hastie, Ph.D., FDA/CBER
Bjoern Peters, Ph.D., La Jolla Institute for Immunology
Robert J. Turesky, Ph.D., University of Minnesota
Sandra Fuentes, Ph.D., FDA/CBER
Jef D. Boeke, Ph.D., NYU Langone Health

2:45 pm - 3:00 pm

 Break

3:00 pm - 4:30 pm ET

 Session 3: Leveraging omics for surveillance, emerging threats, and One Health
Moderator: Carlo Mercado, Ph.D., FDA/CVM
Scott A. Jackson, Ph.D., NIST
Helena M. Solo-Gabriele, Ph.D., University of Miami
Daniel Cornforth, M.S., Ph.D., CDC
Lauren Ahart, M.P.H., CDC

4:30 pm

 Closing Remarks
Alexis Norris, Ph.D., FDA/CVM (FDA Omics Working Group co-chair)

*Sandwiches and salads will be available for purchase in the Great Room lobby

**Poster session: live in-person poster session; some pre-recorded poster presentations will be livestreamed during this time, for our virtual attendees.
Back to the top

Past Event 

FDA Omics Days 2023

Event Materials

Title File Type/Size
fda-omics-days-2024_full-agenda_public_v03.pdf pdf (527.62 KB)
Omics-Days-2024_poster_abstract_booklet _v2.pdf pdf (460.66 KB)
Back to Top